Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx
Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx
批准号:
8242878
负责人:
CONNIE L CELUM
金额:
$75.7万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-17 至 2014-03-31
关键词:
AIDS preventionAccountingAdultAfricaAfrica South of the SaharaAfricanAreaBehavior TherapyBehavior assessmentBehavioralClinical TrialsCommunitiesContractsCounselingCoupledCouplesDataData CollectionEpidemicEpidemiologic StudiesEpidemiologistEpidemiologyEvaluationFoundationsFutureGeneral PopulationHIVHIV InfectionsHeterosexualsHome environmentHouseholdHuman immunodeficiency virus testIncidenceIndividualInterventionIntervention TrialKnowledgeLinkLow PrevalenceMagicMale CircumcisionMeasurementMethodologyPersonsPopulationPopulation Attributable RisksPrevalencePreventionPrevention programPrevention strategyPreventive InterventionProtocols documentationRandomizedResearch PersonnelRiskRisk FactorsRisk ReductionSexually Transmitted DiseasesSouthern AfricaTarget PopulationsTestingUgandaVirusabstractingbasecondomscostcost effectivedesigneffectiveness trialevidence basehigh riskhigh risk behaviormathematical modelpandemic diseasepopulation basedprevention serviceprogramsrandomized trialsexsuccesssystematic reviewtransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract:
The generalized HIV epidemics in sub-Saharan Africa are characterized by high population prevalences, low
knowledge of HIV serostatus, and the majority of HIV transmissions occurring within stable heterosexual
partnerships. No single HIV prevention strategy will control the African HIV epidemic; thus, multi-layered and
multi-component prevention will be needed. We propose to develop a coordinated, multi-component HIV
prevention package of evidence-based biomedical and behavioral interventions that will be individually-tailored
and targeted to maximize coverage and impact on HIV incidence in an African population. The package will be
delivered through a community-based platform of household-based VCT (HBCT) to enhance population-level
coverage and knowledge of serostatus, coupled to community-level delivery of key prevention messages.
HBCT has been demonstrated to be feasible, acceptable and cost-effective in East Africa and provides a
uniquely suitable mechanism to identify persons unaware of their HIV infection, HIV discordant couples, and
high-risk HIV uninfected persons - high priority populations for targeting HIV prevention. We hypothesize that,
using a HBCT platform, it is feasible and acceptable to deliver an individualized "HIV prevention prescription"
to critical subpopulations with high levels of coverage, combining appropriate biomedical and behavioral
interventions that are likely to synergistically reduce population-level HIV transmission in the generalized
African heterosexual epidemic. Our Specific Aims are to: 1. Conduct epidemiologic analyses, systematic
reviews, and mathematical modeling to identify modifiable determinants of heterosexual HIV
transmission with the highest population-attributable fraction in sub-Saharan Africa, estimate the
impact of targeted prevention strategies directed at these determinants, and select components of a
prevention package based on these analyses. 2. Pilot data collection for identification of highest-risk
individuals (HIV discordant couples, HIV-infected persons, and HIV-negative persons with high-risk
behaviors) with integration and targeting of behavioral and biomedical prevention interventions into
population-based HBCT programs. 3. Design a community-randomized effectiveness trial of a
comprehensive, targeted, biomedical and behavioral HIV prevention package for East and southern
Africa in the context of HBCT. Our multi-disciplinary team includes epidemiologists, mathematical modelers,
biostatisticians, and investigators with extensive expertise in conducting multi-center biomedical and behavioral
intervention trials in Africa. We propose HBCT as a platform to deliver community-wide behavioral assessment
of HIV risk and to provide individualized, multi-component biomedical (e.g., male circumcision, ART) and
behavioral HIV prevention packages to at-risk individuals. This targeted "prevention prescription" will be the
foundation for the product of this proposal: a design and protocol for a future community-randomized trial of a
multi-component HIV prevention package for the generalized heterosexual epidemics in sub-Saharan Africa.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1097/qai.0b013e318237b864
发表时间:
2012-01-01
期刊:
Journal of acquired immune deficiency syndromes (1999)
影响因子:
--
作者:
[Ndase P, Celum C, Thomas K, Donnell D, Fife KH, Bukusi E, Delany-Moretlwe S, Baeten JM, Partners in Prevention HSVHIV Transmission Study Team]
通讯作者:
Partners in Prevention HSVHIV Transmission Study Team
DOI:
10.1371/journal.pone.0051620
发表时间:
2012
期刊:
PloS one
影响因子:
3.7
作者:
[Tumwebaze H, Tumwesigye E, Baeten JM, Kurth AE, Revall J, Murnane PM, Chang LW, Celum C]
通讯作者:
Celum C
DOI:
10.1080/13691058.2014.992045
发表时间:
2015
期刊:
Culture, health & sexuality
影响因子:
--
作者:
[Humphries H, van Rooyen H, Knight L, Barnabas R, Celum C]
通讯作者:
Celum C
DOI:
10.1136/sextrans-2012-050651
发表时间:
2013-03
期刊:
Sexually transmitted infections
影响因子:
3.6
作者:
[Chemaitelly H, Abu-Raddad LJ]
通讯作者:
Abu-Raddad LJ
DOI:
10.1097/qad.0b013e32834b005d
发表时间:
2011-10-23
期刊:
AIDS (London, England)
影响因子:
--
作者:
[Were E, Curran K, Delany-Moretlwe S, Nakku-Joloba E, Mugo NR, Kiarie J, Bukusi EA, Celum C, Baeten JM, Partners in Prevention HSVHIV Transmission Study Team]
通讯作者:
Partners in Prevention HSVHIV Transmission Study Team
共 13 条
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men
-
批准号:10376318
-
项目类别:
-
资助金额:$258.67万
-
财政年份:2019
-
负责人:CONNIE L CELUM
-
依托单位:
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men
-
批准号:10599168
-
项目类别:
-
资助金额:$141.24万
-
财政年份:2019
-
负责人:CONNIE L CELUM
-
依托单位:
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men
-
批准号:9914211
-
项目类别:
-
资助金额:$146.43万
-
财政年份:2019
-
负责人:CONNIE L CELUM
-
依托单位:
PrEP for Young South African Women: Evaluating Uptake by Risk Screening or a Decision Support Tool and Scaled Adherence Support Using a SMART Design
-
批准号:9404078
-
项目类别:
-
资助金额:$70.04万
-
财政年份:2017
-
负责人:CONNIE L CELUM
-
依托单位:
HIV self-testing and PrEP to increase testing and prevention uptake among male partners and improve postpartum ART use in PMTCT B+ programs in Uganda
-
批准号:9895861
-
项目类别:
-
资助金额:$65.52万
-
财政年份:2017
-
负责人:CONNIE L CELUM
-
依托单位:
PrEP for Young South African Women: Evaluating Uptake by Risk Screening or a Decision Support Tool and Scaled Adherence Support Using a SMART Design
-
批准号:10175041
-
项目类别:
-
资助金额:$58.42万
-
财政年份:2017
-
负责人:CONNIE L CELUM
-
依托单位:
Interventions to decrease HIV infectiousness in Uganda
-
批准号:8722105
-
项目类别:
-
资助金额:$51.37万
-
财政年份:2013
-
负责人:CONNIE L CELUM
-
依托单位:
Interventions to decrease HIV infectiousness in Uganda
-
批准号:8447165
-
项目类别:
-
资助金额:$115.92万
-
财政年份:2012
-
负责人:CONNIE L CELUM
-
依托单位:
Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx
-
批准号:8077722
-
项目类别:
-
资助金额:$51.17万
-
财政年份:2010
-
负责人:CONNIE L CELUM
-
依托单位:
Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx
-
批准号:8130323
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2010
-
负责人:CONNIE L CELUM
-
依托单位:
Interventions to decrease HIV infectiousness in Uganda
-
批准号:8044884
-
项目类别:
-
资助金额:$390.0万
-
财政年份:2010
-
负责人:CONNIE L CELUM
-
依托单位:
Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx
-
批准号:7680593
-
项目类别:
-
资助金额:$92.42万
-
财政年份:2009
-
负责人:CONNIE L CELUM
-
依托单位:
Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx
-
批准号:8048034
-
项目类别:
-
资助金额:$77.2万
-
财政年份:2009
-
负责人:CONNIE L CELUM
-
依托单位:
Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx
-
批准号:7807119
-
项目类别:
-
资助金额:$84.5万
-
财政年份:2009
-
负责人:CONNIE L CELUM
-
依托单位:
Clinical Research
-
批准号:7479024
-
项目类别:
-
资助金额:$19.6万
-
财政年份:2008
-
负责人:CONNIE L CELUM
-
依托单位:
Core-Clinical Research
-
批准号:6896686
-
项目类别:
-
资助金额:$11.64万
-
财政年份:2004
-
负责人:CONNIE L CELUM
-
依托单位:
Acylovir to prevent HIV acquisition in HSV-2+persons
-
批准号:6607162
-
项目类别:
-
资助金额:$248.18万
-
财政年份:2002
-
负责人:CONNIE L CELUM
-
依托单位:
Acyclovir to Prevent HIV Acquisition in HSV-2+ Persons
-
批准号:7005128
-
项目类别:
-
资助金额:$436.38万
-
财政年份:2002
-
负责人:CONNIE L CELUM
-
依托单位:
Acylovir to prevent HIV acquisition in HSV-2+persons
-
批准号:6496544
-
项目类别:
-
资助金额:$257.19万
-
财政年份:2002
-
负责人:CONNIE L CELUM
-
依托单位:
Acyclovir to Prevent HIV Acquisition in HSV-2+ Persons
-
批准号:7117844
-
项目类别:
-
资助金额:$483.87万
-
财政年份:2002
-
负责人:CONNIE L CELUM
-
依托单位:
海外基金